A trio of deals amounting to a combined $45bn breathed fresh life into the healthcare mergers and acquisitions boom yesterday as Abbott Laboratories, AbbVie and Sanofi all went shopping for assets. The largest was Abbott's $30bn agreed takeover of St ...